Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Basal Insulin and Basal-Bolus Therapy in Patients with Type 2 Diabetes Based on Attainment of Clinically Relevant Treatment Targets.
Cannon, Anthony J
Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Basal Insulin and Basal-Bolus Therapy in Patients with Type 2 Diabetes Based on Attainment of Clinically Relevant Treatment Targets. [electronic resource] - Journal of managed care & specialty pharmacy Feb 2020 - 143-153 p. digital
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
2376-1032
10.18553/jmcp.2019.19035 doi
Adult
Blood Glucose--drug effects
Cost-Benefit Analysis
Diabetes Mellitus, Type 2--drug therapy
Drug Combinations
Glycated Hemoglobin--metabolism
Humans
Hypoglycemia--chemically induced
Hypoglycemic Agents--administration & dosage
Insulin Glargine--administration & dosage
Insulin, Long-Acting--administration & dosage
Liraglutide--administration & dosage
Metformin--administration & dosage
United States
Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Basal Insulin and Basal-Bolus Therapy in Patients with Type 2 Diabetes Based on Attainment of Clinically Relevant Treatment Targets. [electronic resource] - Journal of managed care & specialty pharmacy Feb 2020 - 143-153 p. digital
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
2376-1032
10.18553/jmcp.2019.19035 doi
Adult
Blood Glucose--drug effects
Cost-Benefit Analysis
Diabetes Mellitus, Type 2--drug therapy
Drug Combinations
Glycated Hemoglobin--metabolism
Humans
Hypoglycemia--chemically induced
Hypoglycemic Agents--administration & dosage
Insulin Glargine--administration & dosage
Insulin, Long-Acting--administration & dosage
Liraglutide--administration & dosage
Metformin--administration & dosage
United States